This inventor holds 5 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignees: Ac Immune Sa, Life Molecular Imaging Sa. Active years: 2020-2025.
Company Filing History:
5 out of 68 
1 out of 3 Years Active: 2020-2025
Title: Sreenivasachary Nampally: Innovator in Tau Aggregate Research
Introduction
Sreenivasachary Nampally is a notable inventor based in Ecublens, Switzerland. He has made significant contributions to the field of biomedical research, particularly in the treatment of disorders associated with Tau aggregates. With a total of 5 patents, his work focuses on innovative compounds that address critical health issues.
Latest Patents
Nampally's latest patents include groundbreaking compounds for the treatment or alleviation of disorders associated with Tau aggregates. These compounds are designed to target and mitigate the effects of Neurofibrillary Tangles (NFTs), which are linked to Alzheimer's disease (AD). His inventions aim to provide new therapeutic options for patients suffering from these debilitating conditions.
Career Highlights
Throughout his career, Nampally has worked with prominent companies in the biotechnology sector, including Ac Immune SA and Life Molecular Imaging SA. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical research.
Collaborations
Nampally has collaborated with esteemed colleagues such as Emanuele Gabellieri and Jerome Molette. These partnerships have further enriched his research and development efforts, leading to innovative solutions in the treatment of Tau-related disorders.
Conclusion
Sreenivasachary Nampally's work exemplifies the impact of innovation in addressing complex medical challenges. His contributions to the understanding and treatment of Tau aggregates are paving the way for future advancements in Alzheimer's disease research.